Christine Danel

Summary

Publications

  1. pmc Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability
    April D Kimmel
    Department of Healthcare Policy and Research, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA
    Cost Eff Resour Alloc 10:12. 2012
  2. doi request reprint Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adults
    Christine Danel
    INSERM U897, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS Res Hum Retroviruses 25:783-93. 2009
  3. ncbi request reprint Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa
    Christine Danel
    Programme PAC CI, Abidjan, Cote d Ivoire, France
    J Acquir Immune Defic Syndr 42:29-35. 2006
  4. pmc Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
    Eugene Messou
    Programme PAC, CI, Abidjan, Cote d Ivoire
    Bull World Health Organ 86:435-42. 2008
  5. ncbi request reprint Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa
    Raoul Moh
    Trivacan ANRS 1269 study group, Abidjan, France
    AIDS 21:2483-91. 2007
  6. doi request reprint Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults
    Christine Danel
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    J Infect Dis 199:66-76. 2009
  7. ncbi request reprint Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings
    Didier K Ekouevi
    Programme PACCI, Abidjan, Cote d Ivoire, INSERM, Unité 593, Bordeaux, France
    AIDS Res Hum Retroviruses 23:1469-74. 2007
  8. pmc Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire
    Albert Minga
    Programme PAC CI, Abidjan, Cote d Ivoire
    AIDS Res Hum Retroviruses 26:991-5. 2010
  9. pmc Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire
    Christine Danel
    Programme PAC CI, Abidjan, Ccte d Ivoire
    AIDS Res Hum Retroviruses 23:62-6. 2007
  10. ncbi request reprint HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006
    Bernard Masquelier
    Programme PAC CI Primo CI ANRS 1220, Abidjan, Cote d Ivoire
    AIDS Res Hum Retroviruses 23:1155-60. 2007

Collaborators

Detail Information

Publications27

  1. pmc Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability
    April D Kimmel
    Department of Healthcare Policy and Research, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA
    Cost Eff Resour Alloc 10:12. 2012
    ..abstract:..
  2. doi request reprint Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adults
    Christine Danel
    INSERM U897, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS Res Hum Retroviruses 25:783-93. 2009
    ..After warning signs of failure at 6 months, a large proportion of patients reaches immunovirologic success before 36 months provided there is a high rate of adherence to medication and the absence of early resistance mutations...
  3. ncbi request reprint Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa
    Christine Danel
    Programme PAC CI, Abidjan, Cote d Ivoire, France
    J Acquir Immune Defic Syndr 42:29-35. 2006
    ....
  4. pmc Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
    Eugene Messou
    Programme PAC, CI, Abidjan, Cote d Ivoire
    Bull World Health Organ 86:435-42. 2008
    ..We assessed the gain or loss in body mass index (BMI), alone or in combination with the gain or loss in CD4+ T-cell count (CD4), as a tool for predicting the response to ART...
  5. ncbi request reprint Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa
    Raoul Moh
    Trivacan ANRS 1269 study group, Abidjan, France
    AIDS 21:2483-91. 2007
    ..To estimate the incidence and risk factors of mortality and severe morbidity during the first months following antiretroviral therapy (ART) initiation in West African adults...
  6. doi request reprint Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults
    Christine Danel
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    J Infect Dis 199:66-76. 2009
    ..A randomized trial was launched in Côte d'Ivoire in 2002 to compare continuous antiretroviral treatment (hereafter, "C-ART") to an ART regimen of 2 months off and 4 months on therapy (hereafter, "2/4-ART"). We report the final analysis...
  7. ncbi request reprint Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings
    Didier K Ekouevi
    Programme PACCI, Abidjan, Cote d Ivoire, INSERM, Unité 593, Bordeaux, France
    AIDS Res Hum Retroviruses 23:1469-74. 2007
    ..To accurately target the most appropriate time to start HAART, the CD4 percentage could be more reliable than the absolute count in sub-Saharan African pregnant women...
  8. pmc Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire
    Albert Minga
    Programme PAC CI, Abidjan, Cote d Ivoire
    AIDS Res Hum Retroviruses 26:991-5. 2010
    ..As long as HIV clinicians continue to use stavudine in sub-Saharan Africa, they should watch out for acute unexplained weight loss in patients taking ART, particularly among women and patients with high pre-ART BMI...
  9. pmc Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire
    Christine Danel
    Programme PAC CI, Abidjan, Ccte d Ivoire
    AIDS Res Hum Retroviruses 23:62-6. 2007
    ..There was a surprising lack of nephrological side effects during the 6 months of follow-up, supporting the hypothesis that nephrological tolerance of IDV might be higher in sub-Saharan African individuals than in Americans or Europeans...
  10. ncbi request reprint HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006
    Bernard Masquelier
    Programme PAC CI Primo CI ANRS 1220, Abidjan, Cote d Ivoire
    AIDS Res Hum Retroviruses 23:1155-60. 2007
    ..Compared with a previous study carried out by our group in 2001-2002 in a similar population in Abidjan, our findings confirm the circulation and transmission of HIV-1 carrying key ARV drug resistance mutation...
  11. pmc Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa
    Eugene Messou
    Programme PAC CI ANRS, Abidjan, Côte d Ivoire INSERM, Centre 897, France University of Bordeaux, ISPED, France Laboratoire de Virologie, Universite Paris Descartes, Sorbonne Paris Cité, AP HP, CHU Necker Enfants Malades, Paris CeDReS, CHU de Treichville, Abidjan, Côte d Ivoire and Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 64:211-9. 2013
    ..In sub-Saharan Africa, most HIV-infected patients receive antiretroviral therapy (ART) without virological monitoring. Longitudinal data on secondary resistance are rare...
  12. pmc Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts
    Eric Ouattara
    Programme PACCI, Abidjan, Côte d Ivoire Univ Bordeaux, ISPED, F 33000 Bordeaux, France
    J Int AIDS Soc 16:18059. 2013
    ..Clinical Trial Number: NCT00495651...
  13. pmc Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting
    Francois Rouet
    Centre de Diagnostic et de Recherches sur le SIDA, Abidjan, Cote d Ivoire
    J Clin Microbiol 43:2709-17. 2005
    ..The TaqMan real-time PCR (12 dollars per test) is now routinely used to monitor HIV-1 infection in our laboratory. This technology should be further evaluated in limited-resource countries where strains other than CRF02 are prevalent...
  14. pmc Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire
    Albert Minga
    Programme PAC CI, Abidjan, Cote d Ivoire
    Bull World Health Organ 85:116-23. 2007
    ..To estimate the probability of reaching the criteria for starting highly active antiretroviral therapy (HAART) in a prospective cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire...
  15. ncbi request reprint Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire
    Raoul Moh
    Programme PAC CI, Abidjan, Cote d Ivoire
    Antivir Ther 10:615-24. 2005
    ..We estimated the incidence of haematological disorders during the first 6 months of a zidovudine-containing highly active antiretroviral therapy (HAART) regimen in sub-Saharan African adults receiving cotrimoxazole...
  16. ncbi request reprint CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
    Christine Danel
    Programme PAC CI, Abidjan, Cote d Ivoire
    Lancet 367:1981-9. 2006
    ..We did a randomised trial of structured treatment interruption in Abidjan, Côte d'Ivoire...
  17. pmc Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis
    Xavier Anglaret
    University of Bordeaux, ISPED, Bordeaux, France
    Antivir Ther 18:45-55. 2013
    ..We investigated the conditions under which starting ART early could entail more risks than benefits for patients with high CD4⁺ T-cell counts...
  18. pmc CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters
    Albert K Minga
    Programme PAC CI, Abidjan, Cote d Ivoire, France
    AIDS 25:819-23. 2011
    ..WHO recommends initiating combination antiretroviral treatment at the minimal CD4 cell threshold of 350 cells/μl. In sub-Saharan Africa, the time for a recently infected patient to reach this threshold is unclear...
  19. pmc Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008
    Yao Abo
    Programme PAC CI, Centre Hospitalier Universitaire CHU de Treichville, 18 BP 1954, Abidjan, Cote d Ivoire
    BMC Infect Dis 13:607. 2013
    ..We estimated the incidence of serious morbidity among HIV-infected adults receiving ART in one of these HIV routine care center in sub-Saharan Africa...
  20. pmc Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age
    Eric N Ouattara
    PAC CI Program, CHU de Treichville, Abidjan, Cote d Ivoire
    AIDS 26:625-34. 2012
    ..To project the outcomes of using either efavirenz or nevirapine as part of initial antiretroviral therapy (ART) in women of childbearing age in Côte d'Ivoire...
  21. pmc Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire
    Eugene Messou
    Programme PAC CI ANRS, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 56:356-64. 2011
    ..Medication delivery can be measured accurately in settings with computerized prescription databases. We studied the association between medication possession ratio (MPR), virologic suppression, and resistance to ART in Côte d'Ivoire...
  22. doi request reprint Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire
    Thérèse N'Dri-Yoman
    Programme PAC CI, Abidjan, Cote d Ivoire
    Antivir Ther 15:1029-34. 2010
    ..Here, we estimated the prevalence of untreated HIV-infected adults with negative serum HBsAg and detectable plasma HBV DNA in Côte d'Ivoire...
  23. ncbi request reprint Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire
    Catherine Seyler
    Programme PAC CI, Abidjan, Cote d Ivoire
    Antivir Ther 8:385-93. 2003
    ..To evaluate survival, morbidity, and CD4 and viral load (VL) evolution in HIV-infected adults receiving antiretroviral therapy (ART) in Côte d'Ivoire...
  24. pmc Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire
    Didier K Ekouevi
    Programme PAC CI, Abidjan, Cote d Ivoire
    J Acquir Immune Defic Syndr 56:183-7. 2011
    ..An increasing number of HIV-infected women become pregnant while receiving efavirenz (EFV). We compared the pregnancy outcomes of women exposed to EFV and to nevirapine (NVP) during the first trimester...
  25. ncbi request reprint Primary HIV-1 infection in African children infected through breastfeeding
    Francois Rouet
    CeDReS, CHU de Treichville, Abidjan, Cote d Ivoire
    AIDS 16:2303-9. 2002
    ..To describe acute retroviral syndrome and associated primary viraemia in African children infected with HIV-1 through breastfeeding...
  26. ncbi request reprint WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?
    Gérard Kouamé
    aPAC CI, ANRS Research Site, Abidjan, Côte d Ivoire bInserm, U897, University of Bordeaux, Bordeaux, France cInfectious Diseases Department, Treichville University Hospital, Abidjan, Côte d Ivoire dInserm, UMRS 1018, Université Versailles Saint Quentin, Villejuif eCEPED Centre de Population et Développement, UMR 196, INED, IRD, Universite Paris Descartes, Paris, France
    AIDS 28:1533-5. 2014
    ....
  27. ncbi request reprint Stability of ritonavir soft capsule formulation in patients with and without a refrigerator at home in Côte d'Ivoire
    Christine Danel
    Int J STD AIDS 17:784-5. 2006